Cordis US Executive and Leadership Team

Duke Rohlen, the Chief Executive Officer at Cordis US, directs the company's overall strategy and global operations. Rohlen guides the development and execution of business plans, ensuring alignment with Cordis's mission to advance interventional cardiovascular technologies. Overseeing all functional areas, the Chief Executive Officer drives innovation in minimally invasive devices, including guidewires, catheters, balloons, stents, and vascular closure systems. This leadership role involves fostering a culture of excellence and accountability across the organization. By focusing on market expansion and product development, Duke Rohlen ensures Cordis US maintains its leadership position in treating coronary and peripheral vascular diseases. Rohlen's strategic vision propels the company's commitment to improving patient care through advanced medical solutions.

Anthony Kim, the Director & Chief of Staff to CEO at Cordis US, acts as a key strategic advisor and operational liaison for the Chief Executive Officer. Kim facilitates the execution of strategic initiatives, manages critical projects, and ensures effective communication across executive leadership. The Director & Chief of Staff to CEO supports the CEO in driving organizational alignment and operational efficiency. This role involves coordinating cross-functional teams and preparing strategic analyses to inform decision-making. By streamlining executive operations, Anthony Kim enhances the CEO's capacity to lead Cordis US in its mission to advance cardiovascular care. Kim's support is instrumental in advancing the company's product development and market strategies.

Hernan Domenico, the Head Chief Financial Officer, Finance (Americas) at Cordis US, oversees all financial operations and strategic financial planning for the Americas region. Domenico manages financial reporting, budgeting, forecasting, and investment strategies to support the company's growth objectives. The Head Chief Financial Officer, Finance (Americas) ensures robust financial controls and compliance with regulatory requirements across North and South America. This position involves analyzing market trends and financial performance to identify opportunities for profitability and cost optimization. By providing critical financial insights, Hernan Domenico supports the company's mission to develop and manufacture advanced interventional cardiovascular technologies. Domenico's financial acumen is vital for Cordis US's sustained market presence.

Champ Davis, the Chief Operating Officer at Cordis US, manages the day-to-day operational activities and ensures efficient execution of the company's strategic objectives. Davis oversees manufacturing, supply chain, and operational excellence initiatives, critical for producing high-quality minimally invasive medical devices. The Chief Operating Officer focuses on optimizing production processes and enhancing product delivery to meet global demand for cardiovascular technologies. This role involves close collaboration with R&D and sales teams to ensure seamless product lifecycle management. By driving operational efficiencies, Champ Davis supports Cordis US's commitment to providing advanced solutions for coronary and peripheral vascular diseases. Davis's leadership ensures the reliable availability of essential medical equipment.

Bryan Loo, the President, Asia Pacific at Cordis US, directs the company's strategic growth and operational execution across the Asia Pacific region. Loo oversees market development, sales, and distribution networks, ensuring Cordis US's minimally invasive cardiovascular devices reach healthcare providers throughout the region. The President, Asia Pacific drives regional business performance, adapting global strategies to local market needs and regulatory landscapes. This leadership position involves building strong relationships with key stakeholders and expanding market share for interventional technologies. By focusing on regional expansion, Bryan Loo supports Cordis US's mission to improve patient outcomes in Asia Pacific. Loo's leadership is key to navigating the diverse markets within the region.

Matthew Muscari, the President, Americas at Cordis US, spearheads the company's commercial strategy and operational oversight throughout North and South America. Muscari directs sales, marketing, and business development efforts, focusing on expanding the reach of Cordis US's interventional cardiovascular technologies. The President, Americas ensures alignment between regional operations and the company's global objectives for treating coronary and peripheral vascular diseases. This role involves identifying new market opportunities and strengthening customer relationships within the Americas. By driving regional growth, Matthew Muscari reinforces Cordis US's commitment to delivering advanced medical solutions. Muscari's leadership is pivotal for achieving market leadership in the Americas.

Nancy Pounder, the Chief Human Resources Officer at Cordis US, leads all human capital strategies and organizational development initiatives. Pounder is responsible for talent acquisition, employee engagement, compensation, and benefits programs designed to attract and retain top talent. The Chief Human Resources Officer cultivates a positive and productive work environment that supports Cordis US's commitment to innovation in medical devices. This role involves developing HR policies and programs that align with the company's global business objectives and its mission to treat cardiovascular diseases. By fostering a strong organizational culture, Nancy Pounder ensures the workforce is equipped to drive the development and manufacturing of advanced interventional technologies. Pounder's expertise is crucial for building a high-performing team.